GARDP’s research into novel antibiotic candidates and early-stage drug discovery programs.
Antimicrobial resistance, one of the world’s biggest killers, has reached an alarming tipping point.
Changing the way antibiotics are developed and accessed.
A public-health driven model to tackle AMR.
Our latest news and resources.
Protecting people from the rise and spread of drug-resistant infections.
Supporting efforts to ensure the right antibiotics are developed and reach the people who need them.